Skepticism Greets Rare Disease Drug Maker CANbridge in Hong Kong IPO
Company’s shares tumble 27% in trading debut a week ago, but have stabilized since then on hopes for strong growth of China’s market for drugs to treat rare diseases Key…
Hunterase
